In a recent study published in JAMA Network Open, researchers found that aspirin use may improve survival for bladder and breast cancer.
The study is from the National Cancer Institute. One author is Holli A. Loomans-Kropp, Ph.D., M.P.H.
In the study, the team examined the link of aspirin use with the risk for developing new cancers, as well as cancer-associated survival for bladder, breast, esophageal, gastric, pancreatic, and uterine cancers.
Their analysis included 139,896 people (mean age, 66.4 years) participating in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (1993 to 2001).
The researchers found that aspirin use was not linked to the incidence of any studied cancer type.
Aspirin use at least three times/week was linked to increased survival among patients with bladder and breast cancers.
However, there was no survival benefit with esophageal, gastric, pancreatic, or uterine cancer.
A similar association for bladder and breast cancer was seen for any aspirin use.
The results add to the accumulating evidence that aspirin may improve survival for some cancers, the team says.
If you care about cancer, please read studies about common arthritis drug linked to higher skin cancer risk and findings of adding these foods to your daily meals may help prevent cancer.
For more information about cancer prevention and treatment, please see recent studies about this popular supplement may increase your cancer risk slightly and results showing that some cancer signs can appear many years before diagnosis.
Copyright © 2021 Knowridge Science Report. All rights reserved.
